Difference between revisions of "Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5 (Q9898)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2018, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Mol. Cancer Ther., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Mol. Cancer Ther. | ||
| Property / Published In Name String: Mol. Cancer Ther. / rank | |||
| + | Normal rank | ||
Revision as of 21:07, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sakamuri D
0 references
2018
0 references
Mol. Cancer Ther.
0 references
